RAPT Therapeutics, Inc.
RAPT
$0.906
-$0.0151-1.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 231.06M | 97.91M | 114.84M | 141.58M | 158.86M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.18M | 4.69M | 5.66M | 6.78M | 2.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 235.24M | 102.60M | 120.50M | 148.36M | 161.78M |
|
|
|||||
| Total Current Assets | 235.24M | 102.60M | 120.50M | 148.36M | 161.78M |
| Net Property, Plant & Equipment | 4.70M | 5.48M | 6.24M | 7.01M | 7.68M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 389.00K | 389.00K | 447.00K | 447.00K | 3.87M |
| Total Assets | 240.33M | 108.47M | 127.18M | 155.82M | 173.33M |
|
|
|||||
| Total Accounts Payable | 1.28M | 1.38M | 2.72M | 6.77M | 5.18M |
| Total Accrued Expenses | 44.60M | 6.40M | 9.49M | 11.81M | 14.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.42M | 2.52M | 2.57M | 2.51M | 2.45M |
| Total Finance Division Other Current Liabilities | 57.00K | 61.00K | 30.00K | 82.00K | 109.00K |
| Total Other Current Liabilities | 57.00K | 61.00K | 30.00K | 82.00K | 109.00K |
| Total Current Liabilities | 48.35M | 10.36M | 14.80M | 21.17M | 21.84M |
|
|
|||||
| Total Current Liabilities | 48.35M | 10.36M | 14.80M | 21.17M | 21.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.07M | 2.60M | 3.16M | 3.82M | 4.46M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 50.42M | 12.96M | 17.96M | 24.98M | 26.29M |
|
|
|||||
| Common Stock & APIC | 804.40M | 656.70M | 652.13M | 646.05M | 631.61M |
| Retained Earnings | -614.55M | -561.30M | -542.87M | -515.20M | -484.68M |
| Treasury Stock & Other | 50.00K | 107.00K | -47.00K | -10.00K | 103.00K |
| Total Common Equity | 189.90M | 95.51M | 109.22M | 130.84M | 147.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 189.90M | 95.51M | 109.22M | 130.84M | 147.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 189.90M | 95.51M | 109.22M | 130.84M | 147.04M |
|
|
|||||